Literature DB >> 27481605

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.

Satoshi Minoshima1, Alexander E Drzezga2, Henryk Barthel3, Nicolaas Bohnen4, Mehdi Djekidel5, David H Lewis6, Chester A Mathis7, Jonathan McConathy8, Agneta Nordberg9, Osama Sabri3, John P Seibyl10, Margaret K Stokes11, Koen Van Laere12.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27481605     DOI: 10.2967/jnumed.116.174615

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  42 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

Review 2.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

3.  Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.

Authors:  Kunal P Patel; David T Wymer; Vinay K Bhatia; Ranjan Duara; Chetan D Rajadhyaksha
Journal:  Radiographics       Date:  2020 Jan-Feb       Impact factor: 5.333

4.  [The importance of molecular imaging (PET) in the diagnostics of dementia].

Authors:  M Tscheuschler; M Gebest; F Jessen; A Drzezga
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

5.  Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

Authors:  Matthias Brendel; Jonas Schnabel; Sonja Schönecker; Leonie Wagner; Eva Brendel; Johanna Meyer-Wilmes; Marcus Unterrainer; Andreas Schildan; Marianne Patt; Catharina Prix; Nibal Ackl; Cihan Catak; Oliver Pogarell; Johannes Levin; Adrian Danek; Katharina Buerger; Peter Bartenstein; Henryk Barthel; Osama Sabri; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-20       Impact factor: 9.236

Review 6.  Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?

Authors:  Maureen Dumba; Sairah Khan; Neva Patel; Laura Perry; Paresh Malhotra; Richard Perry; Kuldip Nijran; Tara Barwick; Kathryn Wallitt; Zarni Win
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

7.  Performance study of a radio-frequency field-penetrable PET insert for simultaneous PET/MRI.

Authors:  Chen-Ming Chang; Brian J Lee; Alexander M Grant; Andrew N Groll; Craig S Levin
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-07-03

8.  Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing.

Authors:  Melissa J Armstrong; Gary S Gronseth; Gregory S Day; Carol Rheaume; Slande Alliance; C D Mullins
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

9.  The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.

Authors:  Hye Joo Son; Jungsu S Oh; Minyoung Oh; Soo Jong Kim; Jae-Hong Lee; Jee Hoon Roh; Jae Seung Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-06       Impact factor: 9.236

10.  Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden.

Authors:  Ji-Young Kim; Dongkyu Oh; Kiyoung Sung; Hongyoon Choi; Jin Chul Paeng; Gi Jeong Cheon; Keon Wook Kang; Dong Young Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.